- Home
- Publications
- Publication Search
- Publication Details
Title
Loss of JAK1 Drives Innate Immune Deficiency
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-01-09
DOI
10.3389/fimmu.2018.03108
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The regulation of JAKs in cytokine signaling and its breakdown in disease
- (2018) Henrik M. Hammarén et al. CYTOKINE
- Natural Killer Cells: Development, Maturation, and Clinical Utilization
- (2018) Alex M. Abel et al. Frontiers in Immunology
- Subset- and tissue-defined STAT5 thresholds control homeostasis and function of innate lymphoid cells
- (2017) Alejandro V. Villarino et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Jak3 deficiency blocks innate lymphoid cell development
- (2017) M L Robinette et al. Mucosal Immunology
- JAK inhibition as a therapeutic strategy for immune and inflammatory diseases
- (2017) Daniella M. Schwartz et al. NATURE REVIEWS DRUG DISCOVERY
- Suppressor of Cytokine Signaling 2 Negatively Regulates NK Cell Differentiation by Inhibiting JAK2 Activity
- (2017) Won Sam Kim et al. Scientific Reports
- Development and maturation of natural killer cells
- (2016) Theresa L Geiger et al. CURRENT OPINION IN IMMUNOLOGY
- STAT mutations as program switchers: turning primary immunodeficiencies into autoimmune diseases
- (2016) Tiziana Lorenzini et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Biallelic JAK1 mutations in immunodeficient patient with mycobacterial infection
- (2016) Davide Eletto et al. Nature Communications
- Decreased NK-cell tumour immunosurveillance consequent to JAK inhibition enhances metastasis in breast cancer models
- (2016) Alessia Bottos et al. Nature Communications
- STAT5 Is a Key Regulator in NK Cells and Acts as a Molecular Switch from Tumor Surveillance to Tumor Promotion
- (2016) D. Gotthardt et al. Cancer Discovery
- JAK Inhibition Impairs NK Cell Function in Myeloproliferative Neoplasms
- (2015) Kathrin Schönberg et al. CANCER RESEARCH
- DNAM-1 Expression Marks an Alternative Program of NK Cell Maturation
- (2015) Ludovic Martinet et al. Cell Reports
- Innate immunodeficiency following genetic ablation of Mcl1 in natural killer cells
- (2014) Priyanka Sathe et al. Nature Communications
- Tissue-resident natural killer (NK) cells are cell lineages distinct from thymic and conventional splenic NK cells
- (2014) Dorothy K Sojka et al. eLife
- Important scaffold function of the Janus kinase 2 uncovered by a novel mouse model harboring a Jak2 activation-loop mutation
- (2013) E. Keil et al. BLOOD
- Natural killer cell deficiency
- (2013) Jordan S. Orange JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Liver-resident NK cells confer adaptive immunity in skin-contact inflammation
- (2013) Hui Peng et al. JOURNAL OF CLINICAL INVESTIGATION
- JAKs and STATs in Immunity, Immunodeficiency, and Cancer
- (2013) John J. O'Shea et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sorafenib Sensitizes Solid Tumors to Apo2L/TRAIL and Apo2L/TRAIL Receptor Agonist Antibodies by the Jak2-Stat3-Mcl1 Axis
- (2013) Junaid Abdulghani et al. PLoS One
- CDK8-Mediated STAT1-S727 Phosphorylation Restrains NK Cell Cytotoxicity and Tumor Surveillance
- (2013) Eva Maria Putz et al. Cell Reports
- Regulation of Mouse NK Cell Development and Function by Cytokines
- (2013) Antoine Marçais et al. Frontiers in Immunology
- JAK and STAT Signaling Molecules in Immunoregulation and Immune-Mediated Disease
- (2012) John J. O'Shea et al. IMMUNITY
- The JAK-STAT Pathway at Twenty
- (2012) George R. Stark et al. IMMUNITY
- IL-2 and IL-15 signaling complexes: different but the same
- (2012) Shinji Ikemizu et al. NATURE IMMUNOLOGY
- A novel Ncr1-Cre mouse reveals the essential role of STAT5 for NK-cell survival and development
- (2010) E. Eckelhart et al. BLOOD
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started